|
PARD3B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.18970000021024E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.02909999808188E-08 |
| Normal-vs-Stage2 |
1.57672999999692E-05 |
| Normal-vs-Stage3 |
3.59920000000402E-05 |
| Normal-vs-Stage4 |
2.229700E-02 |
| Stage1-vs-Stage2 |
7.424400E-01 |
| Stage1-vs-Stage3 |
8.713400E-01 |
| Stage1-vs-Stage4 |
7.127400E-01 |
| Stage2-vs-Stage3 |
8.672800E-01 |
| Stage2-vs-Stage4 |
9.059400E-01 |
| Stage3-vs-Stage4 |
8.186400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.53390000490595E-08 |
| Normal-vs-AfricanAmerican |
1.58670000000027E-05 |
| Normal-vs-Asian |
1.636680E-04 |
| Caucasian-vs-AfricanAmerican |
9.245400E-01 |
| Caucasian-vs-Asian |
5.589900E-02 |
| AfricanAmerican-vs-Asian |
8.581900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68809966005767E-10 |
| Normal-vs-Female |
1.722170E-03 |
| Male-vs-Female |
7.418100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.99479999477504E-08 |
| Normal-vs-Extreme_Weight |
6.41790000033282E-08 |
| Normal-vs-Obese |
5.56179999999795E-05 |
| Normal-vs-Extreme_Obese |
4.185000E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.816400E-01 |
| Normal_Weight-vs-Obese |
1.441850E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.275800E-01 |
| Extreme_Weight-vs-Obese |
1.372000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.076600E-01 |
| Obese-vs-Extreme_Obese |
5.967800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.369400E-04 |
| Normal-vs-Age(41-60Yrs) |
4.41080000002092E-06 |
| Normal-vs-Age(61-80Yrs) |
3.63319996310452E-09 |
| Normal-vs-Age(81-100Yrs) |
1.51018999999808E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.623800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.642000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.011000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.071700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.018800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.830200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.11549999529615E-08 |
| Normal-VS-Type2 PRCC |
8.2259000000473E-07 |
| Normal-VS-KIRP CIMP |
4.155100E-03 |
| Normal-VS-Unclassified PRCC |
4.860400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.643200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.102800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.071600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.123800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.176400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.978000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.80090395321508E-11 |
| Normal-vs-N1 |
9.821700E-03 |
| Normal-vs-N2 |
5.621200E-03 |
| N0-vs-N1 |
1.345600E-01 |
| N0-vs-N2 |
8.710600E-01 |
| N1-vs-N2 |
5.826600E-01 |
|
|
